Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome)

C. W. Deveney, K. S. Deveney, B. M. Jaffe, R. S. Jones, L. W. Way

Research output: Contribution to journalArticle

86 Scopus citations

Abstract

65 patients with peptic ulcer disease were evaluated for gastrinoma (Zollinger-Ellison syndrome) by measuring changes in serum gastrin concentration after intravenous (i.v.) administration of calcium or secretin, or both. The presence of gastrinoma was established in all 20 patients whose serum gastrin increased by 395 pg/ml or more after i.v. calcium and in all 18 patients whose serum gastrin concentration increased by 110 pg/ml or more after i.v. secretin. The experience with these 65 patients shows that stimulation by calcium or secretin may confirm the presence of gastrinoma in cases where the diagnosis would otherwise remain obscure. Although a positive response to calcium or secretin is diagnostic for gastrinoma a negative response does not exclude this diagnosis. Stimulation with secretin is preferred for screening for gastrinoma because it is quicker and more reliable than calcium.

Original languageEnglish (US)
Pages (from-to)680-686
Number of pages7
JournalUnknown Journal
Volume87
Issue number6
DOIs
StatePublished - Jan 1 1977

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint Dive into the research topics of 'Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome)'. Together they form a unique fingerprint.

  • Cite this